• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测的血清杀菌活性与志愿者体内测量值的相关性。

Correlation of predicted serum bactericidal activities and values measured in volunteers.

作者信息

Drusano G, Standiford H, Ryan P, McNamee W, Tatem B, Schimpff S

出版信息

Eur J Clin Microbiol. 1986 Feb;5(1):88-92. doi: 10.1007/BF02013475.

DOI:10.1007/BF02013475
PMID:3084247
Abstract

A method was devised for predicting the serum bactericidal activity of new drugs. Six healthy volunteers received 2 g moxalactam, cefoperazone and cefotaxime, respectively, as 30-min infusions in a crossover manner at one-week intervals. The pharmacokinetics of each drug was characterized and the bactericidal activity of the serum 1 h after infusion was measured against panels of six strains of Pseudomonas aeruginosa, six strains of Escherichia coli, six strains of Staphylococcus aureus, and four strains of Klebsiella pneumoniae. The minimum bactericidal concentration of each antibiotic was determined for each organism by the standard NCCLS reference method and the method of Stratton and Reller. On the basis of these values and a serum concentration-time curve constructed from individual patient pharmacokinetic parameters, the bactericidal activity of the serum 1 h after infusion was predicted. These predictions showed a 90% agreement with measured values calculated according to the method of Stratton and Reller, whereas an agreement of 74% was obtained with the reference method. This difference was statistically significant (p less than 0.001).

摘要

设计了一种预测新药血清杀菌活性的方法。6名健康志愿者分别接受2克氨曲南、头孢哌酮和头孢噻肟,以交叉方式每隔一周进行30分钟输注。对每种药物的药代动力学进行了表征,并测定了输注后1小时血清对6株铜绿假单胞菌、6株大肠杆菌、6株金黄色葡萄球菌和4株肺炎克雷伯菌的杀菌活性。通过标准的NCCLS参考方法以及Stratton和Reller的方法,为每种微生物确定了每种抗生素的最低杀菌浓度。根据这些值以及由个体患者药代动力学参数构建的血清浓度-时间曲线,预测了输注后1小时血清的杀菌活性。这些预测结果与根据Stratton和Reller方法计算的测量值有90%的一致性,而与参考方法的一致性为74%。这种差异具有统计学意义(p小于0.001)。

相似文献

1
Correlation of predicted serum bactericidal activities and values measured in volunteers.预测的血清杀菌活性与志愿者体内测量值的相关性。
Eur J Clin Microbiol. 1986 Feb;5(1):88-92. doi: 10.1007/BF02013475.
2
The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.拉氧头孢(羟羧氧酰胺菌素)、头孢哌酮和头孢噻肟的血清杀菌活性。
J Antimicrob Chemother. 1984 Nov;14(5):491-7. doi: 10.1093/jac/14.5.491.
3
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.对健康受试者给予头孢哌酮、头孢噻肟、头孢唑肟和拉氧头孢后血清杀菌活性的评估。
Antimicrob Agents Chemother. 1985 Jul;28(1):55-7. doi: 10.1128/AAC.28.1.55.
4
Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.氨曲南、头孢哌酮和阿米卡星单独或联合使用对大肠杆菌、肺炎克雷伯菌、粘质沙雷氏菌和铜绿假单胞菌的血清杀菌活性。
Antimicrob Agents Chemother. 1984 Aug;26(2):224-7. doi: 10.1128/AAC.26.2.224.
5
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.氨曲南及头孢噻肟单用或联用妥布霉素对铜绿假单胞菌和金黄色葡萄球菌的血清杀菌活性
Antimicrob Agents Chemother. 1981 Oct;20(4):539-41. doi: 10.1128/AAC.20.4.539.
6
Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.头孢哌酮单独及与阿米卡星或美洛西林联合应用对革兰阴性杆菌和金黄色葡萄球菌血清杀菌活性的比较研究。
Infection. 1984 May-Jun;12(3):190-3. doi: 10.1007/BF01640897.
7
In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.去乙酰头孢噻肟的体外活性及其与其母体化合物头孢噻肟的相互作用。
Drugs. 1988;35 Suppl 2:57-61. doi: 10.2165/00003495-198800352-00013.
8
Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.哌拉西林/他唑巴坦对金黄色葡萄球菌、对哌拉西林敏感和耐药的大肠埃希菌以及铜绿假单胞菌的血清杀菌活性。
Chemotherapy. 2004 Apr;50(1):27-30. doi: 10.1159/000077281.
9
Serum bactericidal test in volunteers--a review.志愿者血清杀菌试验——综述
Eur J Clin Microbiol. 1986 Feb;5(1):71-8. doi: 10.1007/BF02013473.
10
Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.环丙沙星在血清和尿液中对大肠杆菌、铜绿假单胞菌、肺炎克雷伯菌、金黄色葡萄球菌和粪肠球菌的杀菌活性。
J Antimicrob Chemother. 1985 Sep;16(3):341-7. doi: 10.1093/jac/16.3.341.

引用本文的文献

1
Seventy-Five Years of Research on Protein Binding.七十五年来的蛋白质结合研究。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01663-17. Print 2018 Feb.
2
Effect of ertapenem protein binding on killing of bacteria.厄他培南蛋白结合对细菌杀灭的影响。
Antimicrob Agents Chemother. 2004 Sep;48(9):3419-24. doi: 10.1128/AAC.48.9.3419-3424.2004.
3
Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.吉米沙星和曲伐沙星在体外尿液中的抗菌特性:I期研究

本文引用的文献

1
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration.血清杀菌活性与抗菌药物水平及最低杀菌浓度的相关性。
J Infect Dis. 1982 Feb;145(2):160-8. doi: 10.1093/infdis/145.2.160.
2
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.羟羧氧酰胺菌素治疗对头孢噻吩耐药菌引起的感染:血清抑制活性对治疗期间临床反应及抗生素耐药性获得的影响
Antimicrob Agents Chemother. 1981 Sep;20(3):351-5. doi: 10.1128/AAC.20.3.351.
3
Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Antimicrob Agents Chemother. 2001 Jun;45(6):1876-8. doi: 10.1128/AAC.45.6.1876-1878.2001.
4
Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities.在预测的和实验性的尿液杀菌活性之间出现差异后,怀疑存在喹诺酮活性代谢物。
Antimicrob Agents Chemother. 1997 May;41(5):927-30. doi: 10.1128/AAC.41.5.927.
5
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.静脉注射环丙沙星在重症患者中的药效学
Antimicrob Agents Chemother. 1993 May;37(5):1073-81. doi: 10.1128/AAC.37.5.1073.
6
Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.健康志愿者多次口服环丙沙星和氧氟沙星后的药代动力学及血清杀菌效价
Antimicrob Agents Chemother. 1993 Oct;37(10):2193-9. doi: 10.1128/AAC.37.10.2193.
7
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.单独使用哌拉西林以及与他唑巴坦联合使用的体外药效学研究,与替卡西林加克拉维酸的比较。
Antimicrob Agents Chemother. 1993 Sep;37(9):1860-8. doi: 10.1128/AAC.37.9.1860.
8
Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.环丙沙星对肺炎链球菌、金黄色葡萄球菌和铜绿假单胞菌菌株的药代动力学和药效学活性,这些菌株的最低抑菌浓度相似。
Antimicrob Agents Chemother. 1994 Dec;38(12):2730-7. doi: 10.1128/AAC.38.12.2730.
9
Technical aspects and clinical correlations of the serum bactericidal test.
Eur J Clin Microbiol. 1986 Feb;5(1):79-87. doi: 10.1007/BF02013474.
10
Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents.血清杀菌试验的标准化及其与抗菌药物水平的关系。
Eur J Clin Microbiol. 1986 Feb;5(1):61-6. doi: 10.1007/BF02013471.
正常志愿者中拉氧头孢、头孢哌酮和头孢噻肟的比较药代动力学
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S585-94. doi: 10.1093/clinids/4.supplement_3.s585.
4
Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.血清和尿液中的抗菌活性作为细菌感染治疗的指导依据。
J Infect Dis. 1974 Feb;129(2):187-93. doi: 10.1093/infdis/129.2.187.
5
Molecular structure of bacterial plasmids.细菌质粒的分子结构。
Bacteriol Rev. 1972 Sep;36(3):361-405. doi: 10.1128/br.36.3.361-405.1972.
6
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.
J Infect Dis. 1977 Aug;136(2):196-204. doi: 10.1093/infdis/136.2.196.
7
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.
J Infect Dis. 1977 Aug;136(2):187-95. doi: 10.1093/infdis/136.2.187.